TriSalus Life Sciences (TLSI) Accumulated Depreciation & Amortization (2022 - 2026)
TriSalus Life Sciences posted quarterly Accumulated Depreciation & Amortization of $135000.0 for Q1 2026, down 21.51% year-on-year from $172000.0 in Q1 2025, and down 78.43% on a QoQ basis from $626000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) has 5 years of Accumulated Depreciation & Amortization data on file, last reported at $135000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 21.51% year-over-year to $135000.0; the trailing twelve-month figure through Mar 2026 stood at $135000.0 (down 21.51% YoY), and the FY2025 full-year result was $626000.0, down 15.86% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $135000.0, down from $626000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $744000.0 in Q4 2024 and bottomed at $135000.0 in Q1 2026.
- The 5-year median for Accumulated Depreciation & Amortization is $398000.0 (2022), against an average of $426454.5.
- The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization soared 71.86%; it then dropped 21.51% in 2026.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $398000.0 in 2022, then surged by 71.86% to $684000.0 in 2023, then rose by 8.77% to $744000.0 in 2024, then decreased by 15.86% to $626000.0 in 2025, then slumped by 78.43% to $135000.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $135000.0 (Q1 2026), $626000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Jun 30, 2025 | 337,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 551,000.00 |
| Sep 30, 2024 | 551,000.00 |
| Jun 30, 2024 | 369,000.00 |
| Jun 30, 2024 | 369,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | 684,000.00 |
| Dec 31, 2023 | 684,000.00 |
| Dec 31, 2022 | 398,000.00 |
| Dec 31, 2022 | 398,000.00 |